Prime Moves Lab Rundown: Axiom Space Raises $350M, Boom Prepares XB-1 Test Flight, & CarbonCapture Secures $12.5M in DOE Funding

Check out the latest headlines from across the Prime Movers Lab portfolio, including Axiom Space’s $350M Series C and Boom Supersonic’s XB-1 progress ahead of test flights in Mojave later this year. Vaxxinity also published positive trial results for its active immunotherapy candidate, UB-311, in Alzheimer’s. In addition, CarbonCapture Inc. and a team of strategic partners received $12.5 million in funding from the United States Department of Energy to initiate the development of a megaton-scale direct air capture hub in Southwest Wyoming. Here are these and other exciting stories from the last month:

CNBC: Axiom Space raises $350 million from Saudi and Korean investors (Axiom Space)

Aviation Week: FAA Clears Boom Supersonic For XB-1 Flight Tests (Boom Supersonic)

Los Angeles Times: How the Biden administration is pouring billions into technology that sucks carbon from the air (CarbonCapture Inc.)

Longevity Technology: Vaxxinity publishes positive results in Alzheimer’s trial (Vaxxinity)

TechCrunch: 7 founders explain what fusion power needs to go mainstream (Focused Energy)

Crunchbase: 6 Tips From An Investor For Raising Money For Your Startup (Prime Movers Lab)

Via Satellite: Quantum Space Exec Details Plan to Open Access to GEO (Quantum Space)

NASA: NASA Selects Axiom Space for Another Private Space Mission in 2024 (Axiom Space)

Prime Movers Lab invests in breakthrough scientific startups founded by Prime Movers, the inventors who transform billions of lives. We invest in seed-stage companies reinventing energy, transportation, infrastructure, manufacturing, human augmentation, and agriculture.